本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Caris Life Sciences, Inc.

27.72
+1.214.56%
盤後27.70-0.0190-0.07%19:46 EDT
成交量:57.30萬
成交額:1,562.98萬
市值:78.60億
市盈率:- -
高:28.20
開:26.83
低:26.75
收:26.51
資料載入中...
2025/06/20

重要事件披露

Form 8-K - Current report
2025/06/18

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/06/16

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/06/09

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/05/24

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2021/06/29

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/21

重要事件披露

8-K - Current report
2021/06/08

重要事件披露

8-K - Current report
2021/05/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/30

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/30

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/29

重要事件披露

8-K - Current report
2021/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals